Latest Insider Transactions at Scholar Rock Holding Corp (SRRK)
This section provides a real-time view of insider transactions for Scholar Rock Holding Corp (SRRK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Scholar Rock Holding Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Scholar Rock Holding Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Mo Qatanani CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,945
-1.96%
|
$11,670
$6.34 P/Share
|
|
Aug 16
2023
|
Caryn Parlavecchio CHRO |
SELL
Open market or private sale
|
Direct |
1,353
-1.14%
|
$8,118
$6.83 P/Share
|
|
Jun 21
2023
|
Caryn Parlavecchio CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,038
-3.29%
|
$32,304
$8.75 P/Share
|
|
Jun 21
2023
|
Junlin Ho GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
4,346
-2.67%
|
$34,768
$8.75 P/Share
|
|
Jun 21
2023
|
Edward H Myles COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,138
-3.38%
|
$57,104
$8.75 P/Share
|
|
Apr 28
2023
|
Invus Public Equities, L.P. |
BUY
Open market or private purchase
|
Direct |
31,557
+0.35%
|
$189,342
$6.43 P/Share
|
|
Feb 13
2023
|
Edward H Myles COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
63,750
+23.21%
|
-
|
|
Feb 13
2023
|
Junlin Ho GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
46,875
+22.34%
|
-
|
|
Feb 13
2023
|
Jay T. Backstrom CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+50.0%
|
-
|
|
Feb 13
2023
|
Caryn Parlavecchio CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
46,875
+27.66%
|
-
|
|
Jan 17
2023
|
Edward H Myles COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,043
-4.57%
|
$77,473
$11.29 P/Share
|
|
Jan 17
2023
|
Junlin Ho GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
4,529
-3.76%
|
$49,819
$11.29 P/Share
|
|
Jan 17
2023
|
Caryn Parlavecchio CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,934
-3.73%
|
$32,274
$11.28 P/Share
|
|
Jan 09
2023
|
Invus Public Equities, L.P. |
SELL
Open market or private sale
|
Direct |
1,094
-0.01%
|
$9,846
$9.48 P/Share
|
|
Jan 05
2023
|
Invus Public Equities, L.P. |
BUY
Open market or private purchase
|
Direct |
48,774
+0.54%
|
$438,966
$9.33 P/Share
|
|
Oct 25
2022
|
Invus Public Equities, L.P. |
BUY
Open market or private purchase
|
Direct |
130,265
+1.43%
|
$1,042,120
$8.04 P/Share
|
|
Oct 04
2022
|
Invus Public Equities, L.P. |
BUY
Open market or private purchase
|
Direct |
66,000
+0.74%
|
$462,000
$7.89 P/Share
|
|
Oct 03
2022
|
Invus Public Equities, L.P. |
BUY
Open market or private purchase
|
Direct |
33,971
+0.39%
|
$237,797
$7.03 P/Share
|
|
Aug 16
2022
|
Caryn Parlavecchio CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,401
-1.75%
|
$15,411
$11.34 P/Share
|
|
Jul 08
2022
|
Michael Gilman |
BUY
Bona fide gift
|
Indirect |
37,459
+50.0%
|
-
|
|
Jul 08
2022
|
Michael Gilman |
SELL
Bona fide gift
|
Direct |
37,459
-100.0%
|
-
|
|
Jun 22
2022
|
Amir Nashat |
BUY
Open market or private purchase
|
Indirect |
1,197,992
+24.22%
|
$4,791,968
$4.9 P/Share
|
|
Jun 16
2022
|
Gregory John Carven Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,500
+26.19%
|
-
|
|
Jun 16
2022
|
Junlin Ho GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
45,500
+27.39%
|
-
|
|
Jun 16
2022
|
Nagesh K. Mahanthappa Interim CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+9.43%
|
-
|
|
Jun 16
2022
|
Edward H Myles COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
74,750
+32.65%
|
-
|
|
Jun 16
2022
|
Caryn Parlavecchio CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
35,750
+30.87%
|
-
|
|
Feb 14
2022
|
Yung H. Chyung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+12.67%
|
-
|
|
Feb 14
2022
|
Nagesh K. Mahanthappa Interim CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Feb 14
2022
|
Gregory John Carven Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+29.73%
|
-
|
|
Feb 14
2022
|
Junlin Ho GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+33.31%
|
-
|
|
Feb 14
2022
|
Edward H Myles COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
57,500
+41.98%
|
-
|
|
Jan 18
2022
|
Gregory John Carven Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,137
-2.33%
|
$21,603
$19.46 P/Share
|
|
Jan 18
2022
|
Yung H. Chyung Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,421
-0.64%
|
$26,999
$19.46 P/Share
|
|
Jan 18
2022
|
Edward H Myles COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,178
-9.02%
|
$41,382
$19.46 P/Share
|
|
Jan 18
2022
|
Junlin Ho GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
1,042
-2.7%
|
$19,798
$19.46 P/Share
|
|
Nov 17
2021
|
Amir Nashat |
BUY
Other acquisition or disposition
|
Direct |
7,441
+25.14%
|
-
|
|
Nov 17
2021
|
Amir Nashat |
SELL
Other acquisition or disposition
|
Indirect |
339,098
-55.0%
|
-
|
|
Nov 17
2021
|
Amir Nashat |
BUY
Other acquisition or disposition
|
Indirect |
56,009
+50.0%
|
-
|
|
Nov 15
2021
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
4,879
-16.81%
|
$170,765
$35.05 P/Share
|
|
Nov 15
2021
|
Edward H Myles COO & CFO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
4,879
+14.39%
|
-
|
|
Nov 12
2021
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
49,848
-67.36%
|
$1,744,680
$35.12 P/Share
|
|
Nov 12
2021
|
Edward H Myles COO & CFO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
49,848
+40.25%
|
-
|
|
Nov 11
2021
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
23,574
-49.4%
|
$825,090
$35.2 P/Share
|
|
Nov 11
2021
|
Edward H Myles COO & CFO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
23,574
+33.06%
|
-
|
|
Oct 01
2021
|
Jeffrey S. Flier |
SELL
Open market or private sale
|
Indirect |
6,000
-21.22%
|
$180,000
$30.89 P/Share
|
|
Sep 20
2021
|
Jeffrey S. Flier |
SELL
Open market or private sale
|
Direct |
500
-5.26%
|
$17,000
$34.09 P/Share
|
|
Jul 26
2021
|
Jeffrey S. Flier |
SELL
Open market or private sale
|
Indirect |
6,000
-9.17%
|
$186,000
$31.66 P/Share
|
|
Mar 15
2021
|
Michael Gilman |
SELL
Open market or private sale
|
Direct |
4,696
-11.14%
|
$305,240
$65.59 P/Share
|
|
Feb 08
2021
|
Michael Gilman |
SELL
Open market or private sale
|
Direct |
1,804
-4.1%
|
$117,260
$65.06 P/Share
|